Literature DB >> 24035198

Trimethoprim/sulfamethoxazole susceptibility of Mycobacterium tuberculosis.

N Alsaad1, T van der Laan, R van Altena, K R Wilting, T S van der Werf, Y Stienstra, D van Soolingen, J W C Alffenaar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24035198     DOI： 10.1016/j.ijantimicag.2013.07.011

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  6 in total

1.  Sulfamethoxazole susceptibility of Mycobacterium tuberculosis isolates from HIV-infected Ugandan adults with tuberculosis taking trimethoprim-sulfamethoxazole prophylaxis.

Authors:  Sam Ogwang; Caryn E Good; Brenda Okware; Mary Nsereko; Michael R Jacobs; W Henry Boom; Charles M Bark
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

2.  Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.

Authors:  Joseph S Cavanaugh; Ruwen Jou; Mei-Hua Wu; Tracy Dalton; Ekaterina Kurbatova; Julia Ershova; J Peter Cegielski
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

3.  Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of Tuberculosis.

Authors:  N Alsaad; J A Dijkstra; O W Akkerman; W C M de Lange; D van Soolingen; J G W Kosterink; T S van der Werf; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

4.  Intra- and extracellular activities of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.

Authors:  L Davies Forsman; T Schön; U S H Simonsson; J Bruchfeld; M Larsson; P Juréen; E Sturegård; C G Giske; K Ängeby
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

Review 5.  Pharmacologic management of Mycobacterium ulcerans infection.

Authors:  Tjip S Van Der Werf; Yves T Barogui; Paul J Converse; Richard O Phillips; Ymkje Stienstra
Journal:  Expert Rev Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.108

6.  Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV.

Authors:  Stephane Wen-Wei Ku; Awachana Jiamsakul; Kedar Joshi; Mark Kristoffer Ungos Pasayan; Alvina Widhani; Romanee Chaiwarith; Sasisopin Kiertiburanakul; Anchalee Avihingsanon; Penh Sun Ly; Nagalingeswaran Kumarasamy; Cuong D Do; Tuti P Merati; Kinh Van Nguyen; Adeeba Kamarulzaman; Fujie Zhang; Man Po Lee; Jun Yong Choi; Junko Tanuma; Suwimon Khusuwan; Benedict Lim Heng Sim; Oon Tek Ng; Winai Ratanasuwan; Jeremy Ross; Wing-Wai Wong
Journal:  J Int AIDS Soc       Date:  2019-03       Impact factor: 5.396
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.